WO2000034294A3 - Tumor necrosis factor receptor homologue-1 ('trh1') - Google Patents

Tumor necrosis factor receptor homologue-1 ('trh1') Download PDF

Info

Publication number
WO2000034294A3
WO2000034294A3 PCT/US1999/029400 US9929400W WO0034294A3 WO 2000034294 A3 WO2000034294 A3 WO 2000034294A3 US 9929400 W US9929400 W US 9929400W WO 0034294 A3 WO0034294 A3 WO 0034294A3
Authority
WO
WIPO (PCT)
Prior art keywords
trh1
necrosis factor
tumor necrosis
factor receptor
receptor homologue
Prior art date
Application number
PCT/US1999/029400
Other languages
French (fr)
Other versions
WO2000034294A2 (en
Inventor
Michael A Bowen
Nathan Siemers
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to AU27080/00A priority Critical patent/AU2708000A/en
Priority to EP99968873A priority patent/EP1135412A2/en
Priority to CA002354612A priority patent/CA2354612A1/en
Priority to JP2000586737A priority patent/JP2002531112A/en
Publication of WO2000034294A2 publication Critical patent/WO2000034294A2/en
Publication of WO2000034294A3 publication Critical patent/WO2000034294A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Abstract

The present invention discloses the identification of the new human tumor necrosis factor receptor homologue ('TRH1'), as identified by its nucleic acid and amino acid sequences disclosed herein. The invention also includes methods of using the nucleic acid sequence, the TRH1 protein, a monoclonal antibody specific for the novel tumor necrosis factor receptor, a ligand for the novel tumor necrosis factor receptor, and fusion proteins comprising all or a portion of the TRH1 disclosed herein.
PCT/US1999/029400 1998-12-11 1999-12-10 Tumor necrosis factor receptor homologue-1 ('trh1') WO2000034294A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU27080/00A AU2708000A (en) 1998-12-11 1999-12-10 Tumor necrosis factor receptor homologue-1 ("trh1")
EP99968873A EP1135412A2 (en) 1998-12-11 1999-12-10 Tumor necrosis factor receptor homologue-1 (trh1)
CA002354612A CA2354612A1 (en) 1998-12-11 1999-12-10 Tumor necrosis factor receptor homologue-1 ("trh1")
JP2000586737A JP2002531112A (en) 1998-12-11 1999-12-10 Tumor necrosis factor receptor homolog-1

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11182698P 1998-12-11 1998-12-11
US60/111,826 1998-12-11

Publications (2)

Publication Number Publication Date
WO2000034294A2 WO2000034294A2 (en) 2000-06-15
WO2000034294A3 true WO2000034294A3 (en) 2000-10-26

Family

ID=22340643

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/029400 WO2000034294A2 (en) 1998-12-11 1999-12-10 Tumor necrosis factor receptor homologue-1 ('trh1')

Country Status (5)

Country Link
EP (1) EP1135412A2 (en)
JP (1) JP2002531112A (en)
AU (1) AU2708000A (en)
CA (1) CA2354612A1 (en)
WO (1) WO2000034294A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358508B1 (en) 1997-06-11 2002-03-19 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR9
CN1329086A (en) * 2000-06-21 2002-01-02 上海博德基因开发有限公司 A novel polypeptide-human TNFR/NGFR protein 15 contaiing cytochrome C structural domain and polynucleotide for coding this polypeptide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0869179A1 (en) * 1997-04-02 1998-10-07 Smithkline Beecham Corporation Tumor necrosis related receptor, TR7
WO1998056892A1 (en) * 1997-06-11 1998-12-17 Human Genome Sciences, Inc. Human tumor necrosis factor receptor tr9

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0869179A1 (en) * 1997-04-02 1998-10-07 Smithkline Beecham Corporation Tumor necrosis related receptor, TR7
WO1998056892A1 (en) * 1997-06-11 1998-12-17 Human Genome Sciences, Inc. Human tumor necrosis factor receptor tr9

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EST, ADAMS ET AL.: "Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotide of cDNA sequence" *
DATABASE EST, HILLIER ET AL.: "Generation and analysis of 280,000 human expressed sequence tags" *
DATABASE GENEMBL, (PATHOLOGY, UNIVERSITY OF MICHIGAN MEDICAL SCHOOL, ANN ARBOR, MI, USA),; PAN ET AL.: "Identification and Functional Characterization of DR6 a Novel Death Domain-containing TNF Receptor" *
GENE SEQUENCE, 5 September 1998 (1998-09-05) *
GENE SEQUENCE, GENOME RES.,, vol. 6, no. 9, 11 December 1996 (1996-12-11), pages 807 - 828 *
GENE SEQUENCE, NATURE,, vol. 377, no. 6547 SUPPL., 21 April 1997 (1997-04-21), pages 3 - 174 *

Also Published As

Publication number Publication date
WO2000034294A2 (en) 2000-06-15
JP2002531112A (en) 2002-09-24
CA2354612A1 (en) 2000-06-15
EP1135412A2 (en) 2001-09-26
AU2708000A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
WO1999020756A3 (en) Human toll homologues
HK1033838A1 (en) Tumor-asociated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and ofcompositions for vaccination
HU9600692D0 (en) Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
EP0960939A3 (en) Dual-tagged proteins and their uses
WO2000020449A3 (en) MODIFIED TGF-β SUPERFAMILY PROTEINS
DK1025236T3 (en) Human checkpoint kinase, HCDS1, preparations and methods
CA2361987A1 (en) Goodpasture antigen binding protein
WO2000034294A3 (en) Tumor necrosis factor receptor homologue-1 ('trh1')
WO1997032022A3 (en) Canine ob protein compositions and methods
EP0816498A3 (en) Excitatory amino acid receptor protein and related nucleic acid compounds
WO2005025603A3 (en) Methods of using wisp antagonists
WO2001002429A3 (en) Angiopoietin-6 and uses thereof
CA2140091A1 (en) Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2
CA2329144A1 (en) New peptide fragments for protein purification
WO1999055876A3 (en) Polypeptide with immunogenic properties and with a protein with modified biological functions
WO1999050288A3 (en) Mammalian blood loss-induced gene, kd312
WO2002016435A3 (en) Human 7tm proteins and polynucleotides encoding the same
WO1997039020A3 (en) Antigenic sequences of a sperm protein and immunocontraceptive methods
WO2002070705A3 (en) Human 7tm proteins and polynucleotides encoding them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 586737

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref document number: 2354612

Country of ref document: CA

Ref country code: CA

Ref document number: 2354612

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 27080/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999968873

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999968873

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999968873

Country of ref document: EP